Lack Of Survival Benefit of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Revascularized Coronary Artery Disease Patients Without History of Myocardial Infarction

被引：0

作者：

Nishino, Tomohiro ^{[1
]}

Furukawa, Yutaka ^{[1
]}

Ehara, Natsuhiko ^{[1
]}

Kaji, Shuichiro ^{[1
]}

Kinoshita, Makoto ^{[1
]}

Kim, Kitae ^{[1
]}

Kitai, Takeshi ^{[1
]}

Yamamuro, Atsushi ^{[1
]}

Kobori, Atsushi ^{[1
]}

Tani, Tomoko ^{[1
]}

Morimoto, Takeshi ^{[2
]}

Kita, Toru ^{[1
]}

Kimura, Takeshi ^{[3
]}

机构：

[1] Gen Hosp, Kobe City Med Cntr, Kobe, Hyogo, Japan

[2] Kyoto Univ, Grad Sch Med, Cntr Med Educ, Kyoto, Japan

[3] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan

来源：

CIRCULATION | 2011年 / 124卷 / 21期

关键词：

ACE inhibitor; Outcomes; Myocardial revascularization; Coronary heart disease; Cardioprotective drugs;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A10587

引用

页数：2

共 50 条

[21] Are angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers teratogenic?
Morton, A. P.
DIABETIC MEDICINE, 2013, 30 (10) : 1263 - 1264
[22] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for the Prevention of Migraines
Gales, Barry J.
Bailey, Emilee K.
Reed, Ashley N.
Gales, Mark A.
ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 360 - 366
[23] Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers
Tazkarji, Bachir
Ganeshamoorthy, Ambika
Auten, Beth
AMERICAN FAMILY PHYSICIAN, 2015, 91 (03) : 193 - 194
[24] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy
Dillon, JJ
SEMINARS IN NEPHROLOGY, 2004, 24 (03) : 218 - 224
[25] Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus
Verdecchia, Paolo
Angeli, Fabio
Reboldi, Gianpaolo
JOURNAL OF HYPERTENSION, 2020, 38 (06) : 1190 - 1191
[26] Angioedema Related to Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Nguyen, Timothy
JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (09): : 690 - 691
[27] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
Kaplan, Norman M.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (08) : 582 - 583
[28] Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease
Ferrari, Paolo
NEPHROLOGY, 2007, 12 (01) : 81 - 89
[29] Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure
Chen, Runzhen
Liu, Chen
Zhou, Peng
Li, Jiannan
Zhou, Jinying
Wang, Ying
Zhao, Xiaoxiao
Chen, Yi
Yan, Shaodi
Song, Li
Zhao, Hanjun
Yan, Hongbing
FRONTIERS IN PHARMACOLOGY, 2022, 13
[30] Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p
Sanchis-Gomar, Fabian
Lavie, Carl J.
Perez-Quilis, Carme
Henry, Brandon M.
Lippi, Giuseppe
MAYO CLINIC PROCEEDINGS, 2020, 95 (06) : 1222 - 1230

← 1 2 3 4 5 →